$CIHN Swank went on to say: "We at CIHN and RBS know that stem cells can work wonders and are pleased that our web site admissions program is operational, and our patient coordinators are doing their job. I am personally very gratified to announce eight patients have now been fully qualified, and three are ready to go to the DR in the next two weeks, for their procedures to commence under the guidance of Dr. Liriano. Since our contract was signed with Dr. Liriano on February 1st in New York, our day-to-day business has become more exciting for all of us here at CIHN, and the promise of great business to come seems inevitable to myself and our employees."
(0)
(0)
BioStem Technologies, Inc. (BSEM) Stock Research Links